{"id":"W2594107028","doi":"10.1182/blood.v126.23.1532.1532","title":"Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bendamustine; Obinutuzumab; Medicine; Rituximab; Internal medicine; Quality of life (healthcare); Clinical endpoint; Refractory (planetary science); Lymphoma; Phases of clinical research; Oncology; Surgery; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004525497,0.0009434557,0.002195522,0.0004786555,0.0004219574,0.001207486,0.0005368666,0.0006679161,0.00268515],"category_scores_gemma":[0.002583515,0.0002997606,0.003017063,0.0004704678,0.0004983411,0.0005849849,0.0005106038,0.001675452,0.0004234203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000796316,"about_ca_system_score_gemma":0.0006548442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006049054,"about_ca_topic_score_gemma":0.001171834,"domain_scores_codex":[0.9977345,0.001390983,0.0001574343,0.0002815631,0.0002506197,0.0001848275],"domain_scores_gemma":[0.9974261,0.0006850676,0.001012905,0.0001050294,0.0002325858,0.000538335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8660474,0.007018102,0.06193651,0.001806682,0.01494842,0.00008547282,0.000128971,0.001645162,0.005005565,0.0001143492,0.003662098,0.03760124],"study_design_scores_gemma":[0.2816348,0.2131009,0.4770818,0.0002308144,0.01594291,0.000272937,0.0001418862,0.002428114,0.004036316,0.0004744497,0.004552993,0.0001019898],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9793844,0.01051577,0.0005370906,0.0004519689,0.0001898886,0.001538103,0.004748226,0.00004459311,0.002590051],"genre_scores_gemma":[0.9940515,0.0008567097,0.0004781331,0.0004004845,0.0001353761,0.001210905,0.002054119,0.000009981031,0.0008028089],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004525497,"threshold_uncertainty_score":0.02393341,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03667813950631183,"score_gpt":0.3057816624668234,"score_spread":0.2691035229605116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}